Clinical Immunology Service

Organisational unit: Department

Publications

  1. 2021
  2. Published
  3. Published
  4. Published
  5. Published
  6. Published

    Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

    & 9 others, , , , , , , , & , 29 Jun 2021, In: Cell Reports. 35, 13, 24 p., 109292.

    Research output: Contribution to journalArticlepeer-review

  7. E-pub ahead of print
  8. Published

    Understanding COVID-19: are children the key?

    Alex Richter, Zania Stamataki & , 15 May 2021, In: BMJ Paediatrics Open. 5, 1, e001063.

    Research output: Contribution to journalReview articlepeer-review

  9. E-pub ahead of print

    Reply to G. Gui et al

    Aimee Jackson & Sylvie Freeman, 5 May 2021, (E-pub ahead of print) In: Journal of Clinical Oncology.

    Research output: Contribution to journalComment/debatepeer-review

  10. E-pub ahead of print
  11. Published

    Future developments: measurable residual disease

    Sylvie Freeman, May 2021, Acute Myeloid Leukemia. Röllig, C. & Ossenkoppele, G. J. (eds.). 1 ed. Springer, p. 317-337 21 p. (Hematologic Malignancies (HEMATOLOGIC)).

    Research output: Chapter in Book/Report/Conference proceedingChapter

  12. Published
  13. E-pub ahead of print
  14. Published
  15. Published
  16. E-pub ahead of print
  17. 2020
  18. E-pub ahead of print
  19. E-pub ahead of print

    Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

    Sylvie Freeman, , , , , , , & , 23 Dec 2020, (E-pub ahead of print) In: Journal of Clinical Oncology . p. JCO2001170

    Research output: Contribution to journalArticlepeer-review

  20. E-pub ahead of print
  21. E-pub ahead of print

    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    8 Dec 2020, (E-pub ahead of print) In: The Lancet. 397, 10269, p. 99-111 13 p.

    Research output: Contribution to journalArticlepeer-review

  22. Published
  23. Published
  24. Published
  25. E-pub ahead of print

    How to establish an academic SARS-CoV-2 testing laboratory

    Alex Richter, , , , , , , , Thomas White, , Jeremy Mirza, & Alan McNally, 2 Nov 2020, (E-pub ahead of print) In: Nature Microbiology.

    Research output: Contribution to journalArticle

  26. E-pub ahead of print

    Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.

    Sylvie Freeman, , , , , , & , Oct 2020, (E-pub ahead of print) In: JAMA Oncology.

    Research output: Contribution to journalArticlepeer-review

  27. E-pub ahead of print

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML).

    Sylvie Freeman & , Oct 2020, (E-pub ahead of print) In: British Journal of Haematology.

    Research output: Contribution to journalArticlepeer-review

  28. Published
  29. E-pub ahead of print
  30. Accepted/In press
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
  36. E-pub ahead of print

    Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting

    Sylvie Freeman & 4 others, , , & , 2 Apr 2020, (E-pub ahead of print) In: British Journal of Haematology.

    Research output: Contribution to journalArticlepeer-review

  37. Published

    The benefits of physical exercise for the health of the pancreatic β-cell: a review of the evidence

    Mark Drayson, , , Jonathan Barlow, Thomas Solomon & Parth Narendran, 1 Apr 2020, In: Experimental Physiology. 105, 4, p. 579-589 11 p.

    Research output: Contribution to journalReview articlepeer-review

  38. Published

    Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels

    Jennifer Heaney, Alex Richter, , , , , , & Mark Drayson, Apr 2020, In: Haematologica. 105, 4, p. e169-e171 3 p.

    Research output: Contribution to journalLetterpeer-review

  39. Published
  40. Published

    Molecular MRD status and outcome after transplantation in NPM1-mutated AML

    Robert Hills, Sylvie Freeman & 19 others, , Igor Novitzky Basso, , , , , , , , , , , , , , , , & , 27 Feb 2020, In: Blood. 135, 9, p. 680-688 9 p.

    Research output: Contribution to journalArticlepeer-review

  41. E-pub ahead of print

    The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer

    Akshay Patel, Alex Richter, Mark Drayson & Gary Middleton, 4 Jan 2020, (E-pub ahead of print) In: Cancer Immunology Immunotherapy.

    Research output: Contribution to journalArticlepeer-review

  42. E-pub ahead of print

    A novel, heterozygous three base-pair deletion in CARD11 results in B cell expansion with NF-κB and T cell anergy disease

    Adrian Shields, , , , & , 2 Jan 2020, (E-pub ahead of print) In: Journal of Clinical Immunology.

    Research output: Contribution to journalLetterpeer-review

  43. Published
  44. 2019
  45. E-pub ahead of print

    In-house age-specific reference ranges for free light chains measured on the SPAPlus® analyser

    Adrian Shields, , & , 18 Dec 2019, (E-pub ahead of print) In: Annals of Clinical Biochemistry.

    Research output: Contribution to journalArticlepeer-review

  46. Published

    MRD evaluation of AML in clinical practice: are we there yet?

    Sylvie Freeman & , 6 Dec 2019, In: Hematology. 2019, 1, p. 557-569

    Research output: Contribution to journalArticlepeer-review

  47. Published
  48. E-pub ahead of print
  49. Published
  50. Published

    Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

    Mark Drayson, , , , Dickens Pratt, , , , , , , , Anna Whittaker, Peter Hawkey, & , Nov 2019, In: Health Technology Assessment. 23, 62, p. 1-94

    Research output: Contribution to journalArticlepeer-review

  51. Published

    Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

    Sylvie Freeman, , , , , , , , , , , & , 22 Oct 2019, In: Blood Advances. 3, 20, p. 3052-3061 10 p.

    Research output: Contribution to journalArticlepeer-review

  52. Published
  53. Published
Previous 1 2 Next